0001596783-20-000180.txt : 20201005 0001596783-20-000180.hdr.sgml : 20201005 20201005195506 ACCESSION NUMBER: 0001596783-20-000180 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201002 FILED AS OF DATE: 20201005 DATE AS OF CHANGE: 20201005 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chiminski John R CENTRAL INDEX KEY: 0001482197 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36587 FILM NUMBER: 201225152 MAIL ADDRESS: STREET 1: C/O CATALENT, INC. STREET 2: 14 SCHOOLHOUSE ROAD CITY: SOMERSET STATE: NJ ZIP: 08873 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Catalent, Inc. CENTRAL INDEX KEY: 0001596783 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 208737688 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 14 SCHOOLHOUSE ROAD CITY: SOMERSET STATE: NJ ZIP: 08873 BUSINESS PHONE: (732) 537-6200 MAIL ADDRESS: STREET 1: 14 SCHOOLHOUSE ROAD CITY: SOMERSET STATE: NJ ZIP: 08873 FORMER COMPANY: FORMER CONFORMED NAME: PTS Holdings Corp. DATE OF NAME CHANGE: 20140113 4 1 wf-form4_160194209323283.xml FORM 4 X0306 4 2020-10-02 0 0001596783 Catalent, Inc. CTLT 0001482197 Chiminski John R C/O CATALENT, INC. 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873 1 1 0 0 Chair & CEO Common Stock 2020-10-02 4 M 0 100372 31.96 A 404337 D Common Stock 2020-10-02 4 F 0 64053 86.01 D 340284 D Common Stock 2020-10-02 4 M 0 37763 24.44 A 378047 D Common Stock 2020-10-02 4 F 0 22198 86.01 D 355849 D Common Stock 2020-10-02 4 S 0 9191 85.27 D 346658 D Common Stock 2020-10-02 4 S 0 173040 86.05 D 173618 D Options to purchase Common Stock 31.96 2020-10-02 4 M 0 100372 0 D 2016-08-27 2025-08-27 Common Stock 100372.0 0 D Options to purchase Common Stock 24.44 2020-10-02 4 M 0 37763 0 D 2026-07-26 Common Stock 37763.0 0 D This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to implement a plan of financial diversification. Includes restricted stock units. Represents shares withheld to pay the exercise price and applicable withholding taxes associated with the exercise of stock options pursuant to the Rule 10b5-1 trading plan noted in footnote 1. Represents shares sold pursuant to the Rule 10b5-1 trading plan noted in footnote 1. Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $84.57 to $85.565, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $85.57 to $86.46, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. On August 27, 2015, the reporting person was granted options to purchase 100,372 shares of common stock of the Issuer, which vest and become exercisable in four equal annual installments beginning on August 27, 2016. On July 26, 2016, the reporting person was granted options to purchase 151,049 shares of common stock of the Issuer, which vest and become exercisable in four equal annual installments beginning on July 26, 2017. /s/ Jose Ibietatorremendia, attorney-in-fact 2020-10-05